Outbreak of meningococcal disease in and around New Delhi, India, 2005-2006: A report from a tertiary care hospital

Epidemiology and Infection

Volumn 137, Issue 4, 2009, Pages 570-576

  Nair, D ^a,d   Dawar, R ^a   Deb, M ^a   Capoor, M R ^a   Singal, S ^b   Upadhayay, D J ^b   Aggarwal, P ^a   Das, B ^c   Samantaray, J C ^c  

^a SAFDARJUNG HOSPITAL   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d NONE

Author keywords

Antimicrobial resistance; Meningococci; Outbreak; Quinolone

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PENICILLIN G; RIFAMPICIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SMEAR; CEREBROSPINAL FLUID; CHILD; EPIDEMIC; FEMALE; GRAM POSITIVE COCCI; HUMAN; INDIA; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEISSERIA MENINGITIDIS; NONHUMAN; PENICILLIN RESISTANCE; PETECHIA; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; INDIA; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; URBAN POPULATION; YOUNG ADULT;

EID: 67349162413     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268808001398     Document Type: Article

References (36)

1. Janda WM, Knapp JS. Neisseria and Moraxella catarrhalis In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical of Microbiology, 8th edn. Washington, DC: ASM Press, 2003, pp. 585-608.
2. Raja NS, et al. Invasive meningococcal disease in the university of Malaya Medical Centre, Kuala Lumpur, Malaysia. Journal of Postgraduate Medicine 2006: 52: 23-29.
3. World Health Organization. Communicable Disease Department, WHO Regional Office for South East Asia. Meningococcal disease in India, Epidemic and Pandemic Alert response (EPR), CD Alert 2005.
4. Taha MK, et al. Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis. Infection & Immunity 2001; 169: 1971-1973.
5. Manchanda V, Gupta S, Bhalla P. Meningococcal disease: History, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention. Indian Journal of Medical Microbiology 2006; 24: 7-19.
6. Singhal S, et al. Ciprofloxacin resistant Neisseria meningitidis, Delhi, India. Emerging Infectious Diseases 2007; 13: 1614-1616.
7. CDC. Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 1997; 46: RR-10.
8. Vazquez JA, et al. Interlaboratory comparison of agar dilution and E test methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrobial Agents and Chemotherapy 2003; 47: 3430-3434.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document (M100-S16), Vol. 26, Clinical and Laboratory Standards Institute, 2007.Wayne, Pennsylvania.
10. Taha MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology 2000; 32: 855-857.
11. Newcombe J, et al. PCR of peripheral blood for diagnosis of meningococcal disease. Journal of Clinical Microbiology 1996; 34: 1637-1640.
12. Borrow RH, et al. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiology and Infection 1997; 118 111-117.
13. Sachdeva A, et al. Meningococcal disease - outbreak in Delhi. Indian Pediatrics 2005; 42: 547-555.
14. Tunkel AR, et al. Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases 2004; 39: 1267-1284.
15. Van Duren M, Brandtzaeg P, Van Dermeer JWM. Update on Meningococcal disease with emphasis on pathogenesis and clinical management. Clinical Microbiology Reviews 2000; 13: 144-166.
16. Periappuram M, Taylor MRH, Keane CT. Rapid detection of meningococci from petechiae in acute meningococcal infection. Journal of Infection 1995; 31: 201-203.
17. Lodder MC, et al. Prognostic indicators of the outcome of meningococcal disease: A study of 562 cases. Journal of Medical Microbiology 1996; 45: 16-20.
18. Reger LE, Kunz G. Neisseria meningitidis meningitis. The John Hopkins Microbiology Newsletter 2001; 20: 1-3.
19. Erdem G, et al. False positive latex agglutination test with Neisseria meningitidis ACYW135 in a patient with intracranial dermoid. Pediatrics Infectious Disease Journal 1994; 13: 550-551.
20. D'Amato RF, Hochstein L, Fay EA. False-positive latex agglutination test for Neisseria meningitidis groups A and Y povidone-iodine antiseptic contamination of cerebrospinal fluid. Journal of Clinical Microbiology 1990; 28: 2134-2135.
21. Olcen P, et al. Culture diagnosis of meningococcal carriers: yield from different sites and influence of storage in transport medium. Journal of Clinical Pathology 1979; 32: 1222-1225.
22. Pollard AJ, et al. Meningococcal disease in British Columbia. BC Medical Journal 2001; 43: 21-27.
23. Carrol ED, et al. Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Archives of Diseases in Childhood 2000; 83: 271-273.
24. Canada Communicable Disease Report. Neisseria meningitidis with decreased susceptibility to penicillin in Ontario, Canada 1997-2000 2001; 27: 1-4.
25. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document (M100-S15) Clinical and Laboratory Standards Institute, 2005. Wayne, Pennsylvania.
26. Ayyagari A, Dubey ML, Bhandari SK. Sulphadiazine resistant strains of Neisseria meningitidis during an outbreak of meningococcal meningitis. Indian Journal of Medical Research 1987; 85: 249-252.
27. Basu RN, Prasad R, Ichhpujani RL. Meningococcal meningitis in Delhi and other areas. Communicable Diseases Bulletin 1985; 2 1.
28. Annapurna ME, Bhave GG, Mathur M. An outbreak of meningitis caused by Neisseria meningitidis Group A. Journal of Communicable Diseases 1989; 21: 24-26.
29. Tapsall JW, et al. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999. Pathology 2001; 33: 359-361.
30. Oppenheim BA. Antibiotic resistance in Neisseria meningitidis. Clinical Infectious Diseases 1997; 24: S98-S101.
31. Abadi FJ, Yakubu DE, Pennington TH. In vitro activities of meropenem and other antimicrobial agents against British meningococcal isolates. Chemotherapy 1999; 45: 253-257.
32. Jorgensen JH, Crawford SA, Fiebelkorn KR. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms a.ecting some agents. Journal of Clinical Microbiology 2005; 43: 3162-3171.
33. Shultz TR, Tapsall JW, White PA. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrobial Agents and Chemotherapy 2000; 44: 1116.
34. Rainbow J, et al. Rifampin-resistant meningococcal disease. Emerging Infectious Diseases 2005; 11: 977-979.
35. Capoor MR, et al. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin resistant Salmonella causing enteric fever. Journal of Medical Microbiology 2007; 56 1490-1494.
36. Mehta G, Goyal R. Emerging fluoroquinolone resistance in Neisseria meningitidis in India: Cause for concern. Journal of Antimicrobial Chemotherapy 2007; 59: 329-330.